Abstract
We aimed to establish a novel immunoscore (IS) model based on the transcriptomes of tumor tissues to improve the relapse-free survival (RFS) prediction of colorectal cancer (CRC). CIBERSORT was used to estimate the immune cell fractions based on the Gene Expression Omnibus (GEO) database. Then, a least absolute shrinkage and selection operator regression was applied to construct the IS model based on the immune cell fractions. After screening, four GEO databases were included in the CIBERSORT transformation. A total of 13 types of immune cells were selected and constructed an IS model. In the training set (n = 613) and test set (n = 262), the patients in the high-immunoscore group showed a significant poor RFS than that in the low-immunoscore group. Stratified analysis also found similar results in patients with identical age, sex, adjunctive chemotherapy, or TNM stage I-II. Multivariate Cox regression further demonstrated that the IS model was an independent predictor of RFS in CRC. In addition, the IS was highly associated with the expression of several immune checkpoints, inflammatory mediators, cell cycle, and epithelial-mesenchymal transformation regulators in CRC. We proposed a novel IS model for estimating RFS in CRC patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
